In a study published Wednesday in the New England Journal of Medicine, researchers reported 27 members of an extended Colombian family carry extreme genetic risk for Alzheimer's, along with a copy of a protective gene called Christchurch. Cognitive decline in this singular group was delayed by about five years, suggesting that a drug that emulates the gene could have similar effects. |
No comments:
Post a Comment